Genmab — December 2022

[nohope]

You are probably right, we have to go back 10 years to make it look great.I can´t do 10 years, but this 5 years compared to Novo, which steadily pays annual dividend.https://imgur.com/a/DSOpp2a

[GeorgeBest]

5 years looks okay for. Can I get the same return the next 5 years, I’ll be happy

[JKY_VH]

Bulder

[E_L]

Janssen Submits Biologics License Application to U.S. FDA for Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma https://www.prnewswire.com/news-releases/janssen-submits-biologics-license-application-to-us-fda-for-talquetamab-for-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma-301699241.html

[E_L]

just a year after teclistamab; that was dec21 (and approved oct22)

[Sukkeralf]

Thats really nice

[nohope]

Man skulle tro det var Novo der havde indsendt en BLA.

[Vitus]

Ja, så er det godt man har APM og Vestas ….

[Vitus]

Sådan tænker jeg ikke, når Genmab falder fra over kurs 3000 til under kurs 2000…

[gdn55]

Men stiger fra 1875 til godt 3300 fra først i junni

[gdn55]

Derfor er jeg langsigtet, har haft Genmab siden kurs 35,60.

[gentogen]

The anti-interleukin (IL)-8 monoclonal antibody, BMS-986253 combined with nivolumab showed preliminary activity in melanoma progressing on checkpoint inhibitors, as reported in a phase I/II trial presented at ESMO Immuno-Oncology Congress 2022

[gentogen]

Preliminary activity is reported with an anti-IL-8 monoclonal antibody plus nivolumab in melanoma

Combination therapy with BMS-986253 shows promise in patients progressing on checkpoint inhibitors

(dailyreporter.esmo.org)

[ProinvestorNEWS]

Godmorgen Opdateret status oversigt for det Danske OMX C25 Index fra NordStock fredag d. 9. december - købs- og salgsignaler: https://www.proinvestor.com/boards/107957/

[GeorgeBest]

Volume på Genmab ADS var vist ekstraordinær høj i går - næsten 1.4 mill. omsat

[GeorgeBest]

Ret vildt at tænke på at når Epco og Talquetamab bliver godkendte i løbet af næste år, vil der være 8 Genmab udviklede produkter på markedet. Hvad mon bliver nr. 9. Mim8 fra Novo??

[Helge_LarsenPI-redaktør]

Enig GB. Det er vildt og imponerende.

[Helge_LarsenPI-redaktør]

Positive Early Results of Mim8 Pave Way for Testing in Phase 3 Trials https://hemophilianewstoday.com/news/mim8-well-tolerated-early-study-paving-way-phase-3-hemophilia-a-clinical-trials/

[E_L]

on BMS-986253 https://clin.larvol.com/abstract-detail/ESMO-IO 2022/60866587 https://oncologypro.esmo.org/meeting-resources/esmo-immuno-oncology-congress/anti-il-8-bms-986253-nivolumab-nivo-ipilimumab-ipi-in-patients-pts-with-advanced-cancer-update-of-initial-phase-i-results

[gentogen]

Nu vi er ved det, så er efterbehandlngen af Lu AF82422 in Participants With Multiple System Atrophy (AMULET) netop blevet forlænget. Ikke at man kan lægge ret meget i det, men måske alligevel et lille positivt tegn???